MGRC Stock Overview An investment holding company, provides genetics, genomics, immunotherapy, and biopharmaceutical services worldwide. More details
Risk Analysis See All Risk Checks Capture your thoughts, links and company narrative
Malaysian Genomics Resource Centre Berhad Competitors Price History & Performance
Summary of share price highs, lows and changes for Malaysian Genomics Resource Centre Berhad Historical stock prices Current Share Price RM 0.36 52 Week High RM 0.47 52 Week Low RM 0.27 Beta 0.94 1 Month Change 10.61% 3 Month Change 2.82% 1 Year Change -17.05% 3 Year Change -69.07% 5 Year Change -9.88% Change since IPO -61.17%
Recent News & Updates
Third quarter 2024 earnings released: RM0.007 loss per share (vs RM0.044 loss in 3Q 2023) Nov 28
New major risk - Market cap size Nov 06
Malaysian Genomics Resource Centre Berhad Appoints Yap Kok Wei as Independent and Non Executive Director Oct 04
New major risk - Revenue and earnings growth Apr 23
Malaysian Genomics Resource Centre Berhad, Annual General Meeting, Apr 29, 2024 Mar 29
Malaysian Genomics Resource Centre Berhad, Annual General Meeting, Apr 29, 2024 Mar 28 See more updates
Third quarter 2024 earnings released: RM0.007 loss per share (vs RM0.044 loss in 3Q 2023) Nov 28
New major risk - Market cap size Nov 06
Malaysian Genomics Resource Centre Berhad Appoints Yap Kok Wei as Independent and Non Executive Director Oct 04
New major risk - Revenue and earnings growth Apr 23
Malaysian Genomics Resource Centre Berhad, Annual General Meeting, Apr 29, 2024 Mar 29
Malaysian Genomics Resource Centre Berhad, Annual General Meeting, Apr 29, 2024 Mar 28
Malaysian Genomics Resource Centre Berhad Announces Redesignation of Encik Muhammad Badri Bin Hussin to Chief Operating Officer from Director Mar 07
Full year 2023 earnings: EPS and revenues miss analyst expectations Feb 29
Malaysian Genomics Resource Centre Berhad Announces Update on Material Litigation Feb 14
Malaysian Genomics Resource Centre Berhad Appoints Mohammad Hasni Bin Ibrahim as Independent and Non Executive Director Feb 03
Malaysian Genomics Resource Centre Berhad Appoints Datuk Wira Muhammad Faizal Bin Zainol as Independent and Non Executive Director Feb 02
Malaysian Genomics Resource Centre Berhad Announces Re-Designation of Aswath A/L Ramakrishnan as A Non-Audit and Risk Management Committee Member Dec 15 Malaysian Genomics Resource Centre Berhad Provides Material Litigation Update Nov 25
Malaysian Genomics Resource Centre Berhad Appoints Encik Muhammad Badri Bin Hussin, Age 50, as Member of Audit Committee, Date of Change 25 Oct 2023 Oct 26
Malaysian Genomics Resource Centre Berhad Announces Appointment of Encik Muhammad Badri Bin Hussin as Independent and Non Executive Director Oct 21
Malaysian Genomics Resource Centre Berhad Announces Appointment of Encik Mohamad Ruzaini Bin Hamzah as Independent and Non Executive Director Oct 18
Malaysian Genomics Resource Centre Berhad Announces Resignation of Encik Sasha Omar Firdaus Bin Aamir Nordin as Chief Executive Officer Sep 14
Full year 2023 earnings released: RM0.11 loss per share (vs RM0.059 profit in FY 2022) Aug 30 Malaysian Genomics Resource Centre Berhad Announces Resignation of Aswath A/L Ramakrishnan as Independent and Non Executive Member of Nomination and Remuneration Committee
High number of new and inexperienced directors Jul 01
Malaysian Genomics Resource Centre Berhad Appoints Miss Chih Yi May as Independent and Non Executive Director effective June 1, 2023 Jun 02
High number of new and inexperienced directors Jun 01
Consensus revenue estimates fall by 33% May 30 Malaysian Genomics Resource Centre Berhad Appoints Encik Syed Zulkifli Bin Syed Ismail as Independent and Non Executive Member of Nomination and Remuneration Committee
Third quarter 2023 earnings released: RM0.022 loss per share (vs RM0.016 profit in 3Q 2022) May 24 Malaysian Genomics Resource Centre Berhad Re-designates Encik Mohd Shakir Bin Shahimi to Chairman of Audit Committee
Malaysian Genomics Resource Centre Berhad Appoints Mr. Aswath A/L Ramakrishnan as Independent and Non Executive Director May 11
Is Now An Opportune Moment To Examine Malaysian Genomics Resource Centre Berhad (KLSE:MGRC)? Mar 02
Price target decreased by 13% to RM0.95 Feb 27
Second quarter 2023 earnings released: RM0.01 loss per share (vs RM0.008 profit in 2Q 2022) Feb 26
First quarter 2023 earnings released: EPS: RM0.007 (vs RM0.002 in 1Q 2022) Nov 24 Malaysian Genomics Resource Centre Berhad Announces the Re-Designation of Encik Mohd Shakir Bin Shahimi from Member of Nomination and Remuneration Committee to Chairman of Nomination and Remuneration Committee
High number of new and inexperienced directors Nov 16
Malaysian Genomics Resource Centre Berhad Announces Resignation of Teoh Ai Ling as Principal Officer Oct 29
Full year 2022 earnings released: EPS: RM0.059 (vs RM0.04 loss in FY 2021) Oct 27
High number of new and inexperienced directors Sep 02
Full year 2022 earnings released: EPS: RM0.059 (vs RM0.04 loss in FY 2021) Aug 31 Malaysian Genomics Resource Centre Berhad Appoints Encik Mohd Shakir Bin Shahimi as Member of Nomination and Remuneration Committee
High number of new and inexperienced directors Aug 02
Malaysian Genomics Resource Centre Berhad announces redesignation of Dato' Seri Dr. Chen Chaw Min from Independent Director to Independent and Non Executive Chairman Jul 16
Others Malaysian Genomics Announces Board Changes Jul 15 Malaysian Genomics Resource Centre Berhad Appoints Ku Chong Hong, Designation Chairman of Nomination and Remuneration Committee Directorate Independent and Non Executive, Date of Change 13 Jul 2022
Third quarter 2022 earnings released: EPS: RM0.016 (vs RM0.002 in 3Q 2021) May 24
High number of new and inexperienced directors Apr 27
Malaysian Genomics Resource Centre Berhad Announces the Launch of Its Genetic Screening Plus Personalised Health Supplements Solutions on the Airasia Super App Apr 06
Second quarter 2022 earnings: EPS in line with expectations, revenues disappoint Feb 17
Malaysian Genomics Resource Centre Berhad Announces Re-Designation of Encik Noor Azri Bin Dato' Sri Noor Azerai as Independent Executive Director Feb 16
We Think Malaysian Genomics Resource Centre Berhad (KLSE:MGRC) Can Afford To Drive Business Growth Feb 15
High number of new and inexperienced directors Jan 02
First quarter 2022 earnings: EPS in line with expectations, revenues disappoint Dec 02
High number of new directors Dec 02
Financial Controller Sek Cheah has left the company Dec 01
Senior Independent Non-Executive Chairman Rafiah Salim has left the company Dec 01
Companies Like Malaysian Genomics Resource Centre Berhad (KLSE:MGRC) Are In A Position To Invest In Growth Nov 02
Full year 2021 earnings released: RM0.04 loss per share (vs RM0.062 loss in FY 2020) Sep 24
High number of new directors Sep 02
New 90-day high: RM1.22 Feb 15
New 90-day high: RM1.18 Jan 29
New 90-day high: RM1.11 Jan 08
New 90-day high: RM0.80 Dec 12
Malaysian Genomics Resource Centre Berhad Renames the Audit Committee as Audit and Risk Management Committee Dec 01
First quarter 2021 earnings released: RM0.008 loss per share Dec 01
New 90-day high: RM0.64 Nov 10
Malaysian Genomics Resource Centre Berhad Announces Appointment of ENCIK SASHA OMAR FIRDAUS BIN AAMIR NORDIN as Chief Executive Officer Sep 24
New 90-day high - RM0.53 Aug 03
Malaysian Genomics Resource Centre Berhad Announces Resignation of Encik Robert George Hercus @ Abdul Karim Hercus as Executive Managing Director Jul 01 Shareholder Returns MGRC MY Life Sciences MY Market 7D 1.4% -1.0% 0.2% 1Y -17.0% 0.3% 10.6%
See full shareholder returns
Return vs Market: MGRC underperformed the MY Market which returned 10.6% over the past year.
Price Volatility Is MGRC's price volatile compared to industry and market? MGRC volatility MGRC Average Weekly Movement 5.4% Life Sciences Industry Average Movement 8.6% Market Average Movement 4.8% 10% most volatile stocks in MY Market 10.5% 10% least volatile stocks in MY Market 2.5%
Stable Share Price: MGRC has not had significant price volatility in the past 3 months compared to the MY market.
Volatility Over Time: MGRC's weekly volatility (5%) has been stable over the past year.
About the Company Malaysian Genomics Resource Centre Berhad, an investment holding company, provides genetics, genomics, immunotherapy, and biopharmaceutical services worldwide. It offers genome sequencing of various human, animal, plant, and microbes and other living organisms, such as whole genome and transcriptome sequencing, and metagenomics and metatranscriptomics services. The company also provides genome analysis services comprising bioinformatics services, including reads quality analysis, whole genome assembly, variation analysis of genomes, gene annotation, and exome and transcriptome analysis, as well as other analytical pipelines for processing ChIP-Seq data, annotating and analyzing microRNAs, and analyzing mutations; trait analysis services to screen multiple samples of previously identified genetic markers within plant and animal genomes; and trio sequencing services that provide a detailed view of an individual’s DNA.
Show more Malaysian Genomics Resource Centre Berhad Fundamentals Summary How do Malaysian Genomics Resource Centre Berhad's earnings and revenue compare to its market cap? MGRC fundamental statistics Market cap RM 50.08m Earnings (TTM ) -RM 7.38m Revenue (TTM ) RM 8.88m
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) MGRC income statement (TTM ) Revenue RM 8.88m Cost of Revenue RM 3.49m Gross Profit RM 5.39m Other Expenses RM 12.77m Earnings -RM 7.38m
Last Reported Earnings
Sep 30, 2024
Earnings per share (EPS) -0.054 Gross Margin 60.71% Net Profit Margin -83.09% Debt/Equity Ratio 0%
How did MGRC perform over the long term?
See historical performance and comparison
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2024/12/25 22:41 End of Day Share Price 2024/12/24 00:00 Earnings 2024/09/30 Annual Earnings 2023/12/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources Malaysian Genomics Resource Centre Berhad is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution Seh Kong CGS International Ping-Khoon Choo Kenanga Research
Show 0 more analysts 
